Page last updated: 2024-10-17

n(1)-methylnicotinamide and Liver Neoplasms

n(1)-methylnicotinamide has been researched along with Liver Neoplasms in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ladep, NG1
Dona, AC1
Lewis, MR1
Crossey, MM1
Lemoine, M1
Okeke, E1
Shimakawa, Y1
Duguru, M1
Njai, HF1
Fye, HK1
Taal, M1
Chetwood, J1
Kasstan, B1
Khan, SA1
Garside, DA1
Wijeyesekera, A1
Thillainayagam, AV1
Banwat, E1
Thursz, MR1
Nicholson, JK1
Njie, R1
Holmes, E1
Taylor-Robinson, SD1

Other Studies

1 other study available for n(1)-methylnicotinamide and Liver Neoplasms

ArticleYear
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:4

    Topics: Acetylcarnitine; Adolescent; Adult; Africa, Western; Aged; Aged, 80 and over; alpha-Fetoproteins; Bi

2014